Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Behrens

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Vaccine|November 26, 2009
Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responsesAdan C Jirmo, Richard C Koya, Bala Sai Sundarasetty, et al.
Infection|June 26, 2020
Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providersMarta Boffito, Lene Ryom, Christoph Spinner, et al.
Infection|March 22, 2020
Clinical management of ageing people living with HIV in Europe: the view of the care providersMarta Boffito, Lene Ryom, Christoph Spinner, et al.
The Journal of Infectious Diseases|October 12, 2011
The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherinAnnika Kühl, Carina Banning, Andrea Marzi, et al.
Human Gene Therapy|May 18, 2011
Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- miceGustavo Salguero, Bala Sai Sundarasetty, Sylvia Borchers, et al.
AIDS Patient Care and Stds|March 26, 2014
Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysisGeorg Behrens, Bart Rijnders, Mark Nelson, et al.
Emerging Infectious Diseases|September 18, 2020
Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-2018<sup>1</sup>Melanie Stecher, Antoine Chaillon, Christoph Stephan, et al.
JMIR Research Protocols|May 13, 2024
Evaluating the Feasibility, Acceptance, and Beneficial Effects of Online Occupational Therapy for Post-COVID-19 Condition: Protocol for a Randomized Controlled Trial (ErgoLoCo Study)Christina Müllenmeister, Andrea Stoelting, Dominik Schröder, et al.
Pilot and Feasibility Studies|April 22, 2026
App-based self-management program for people dealing with fatigue and trouble concentrating (DiEgO): protocol for participatory development, pilot testing, and qualitative process evaluationTim Schmachtenberg, Nadja Wegner, Imke Schwalm, et al.
Haematologica|February 14, 2018
Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort studyPhilipp Schommers, Daniel Gillor, Marcus Hentrich, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Vaccine|November 26, 2009
Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responsesAdan C Jirmo, Richard C Koya, Bala Sai Sundarasetty, et al.
Infection|June 26, 2020
Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providersMarta Boffito, Lene Ryom, Christoph Spinner, et al.
Infection|March 22, 2020
Clinical management of ageing people living with HIV in Europe: the view of the care providersMarta Boffito, Lene Ryom, Christoph Spinner, et al.
The Journal of Infectious Diseases|October 12, 2011
The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherinAnnika Kühl, Carina Banning, Andrea Marzi, et al.
Human Gene Therapy|May 18, 2011
Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- miceGustavo Salguero, Bala Sai Sundarasetty, Sylvia Borchers, et al.
AIDS Patient Care and Stds|March 26, 2014
Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysisGeorg Behrens, Bart Rijnders, Mark Nelson, et al.
Emerging Infectious Diseases|September 18, 2020
Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-2018<sup>1</sup>Melanie Stecher, Antoine Chaillon, Christoph Stephan, et al.
JMIR Research Protocols|May 13, 2024
Evaluating the Feasibility, Acceptance, and Beneficial Effects of Online Occupational Therapy for Post-COVID-19 Condition: Protocol for a Randomized Controlled Trial (ErgoLoCo Study)Christina Müllenmeister, Andrea Stoelting, Dominik Schröder, et al.
Pilot and Feasibility Studies|April 22, 2026
App-based self-management program for people dealing with fatigue and trouble concentrating (DiEgO): protocol for participatory development, pilot testing, and qualitative process evaluationTim Schmachtenberg, Nadja Wegner, Imke Schwalm, et al.
Haematologica|February 14, 2018
Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort studyPhilipp Schommers, Daniel Gillor, Marcus Hentrich, et al.
Pageof 4